Myo-inositol metabolism in two high-performance laying hen strains at different production periods
Abstract
This study aimed to investigate myo-inositol (MI) metabolism in two high-performance laying hen strains and to assess the effects of MI or mineral phosphorus supplementation at different production periods. Diets were corn-soybean meal-based and supplemented with MI (0, 1, 2, or 3 g/kg feed) in experiment 1 or with mineral phosphorus (0 or 1 g/kg feed) in experiment 2. Following a 4-week feeding period in metabolic units, ten hens per strain (Lohmann Brown-Classic and Lohmann LSL-Classic) and diet were euthanized at 30 weeks of age (experiment 1) and at 19 and 24 weeks of age (experiment 2). Plasma, liver, muscle, and kidney samples were collected from each hen. Tissue MI concentrations were measured using a commercial spectrophotometric kit, and concentrations of insulin and key enzymes (inositol monophosphatase and MI oxygenase) were quantified using ELISA kits. As diets did not affect tissue MI or enzyme concentrations, data from the two experiments were combined for further analysis. Changes across periods suggest that insulin influenced kidney MI oxygenase concentration and consequently played an essential role in the metabolic adaptation to egg laying. The results also indicated that higher liver and muscle MI concentrations in Lohmann Brown-Classic hens are potentially associated with metabolic adaptation to the onset of egg laying. Further research is needed to elucidate the role and regulation of MI in laying hens, particularly at the onset of egg laying.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.